Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study-Reference-Cited by-同舟云学术

Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study

Published:2020-11 Issue:5 Volume:76 Page:487-498
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Tani Shigemasa,Yagi Tsukasa,Matsuo Rei,Kawauchi Kenji,Atsumi Wataru,Matsumoto Naoya,Okumura Yasuo

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis;Yokoyama;Lancet,2007

2. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia;Bhatt;N Engl J Med,2019

3. Marine omega-3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants;Hu;J Am Heart Assoc,2019

4. The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease;Nelson;Postgrad Med,2019

5. Pathophysiology of diabetic dyslipidemia;Hirano;J Atheroscler Thromb,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of omega-3 polyunsaturated fatty acid intake on blood levels of omega-3s in people with chronic atherosclerotic disease: a systematic review;Nutrition Reviews;2023-03-07

2. Comparing the effects of docosahexaenoic and eicosapentaenoic acids on cardiovascular risk factors: Pairwise and network meta-analyses of randomized controlled trials;Nutrition, Metabolism and Cardiovascular Diseases;2023-01

3. Associations of higher fish consumption and lifestyle with lower monocyte/HDL-C ratio in a Japanese population: Implication for the anti-atherosclerotic effect of fish consumption;Journal of Cardiology;2022-11

4. Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate;Journal of Atherosclerosis and Thrombosis;2021-09-01

5. Impact of Dyslipidemia on Ischemic Stroke;Stroke Revisited: Dyslipidemia in Stroke;2021